93 related articles for article (PubMed ID: 2119926)
1. Familial hypoalphalipoproteinemias.
Frohlich J; Westerlund J; Sparks D; Pritchard PH
Clin Invest Med; 1990 Aug; 13(4):202-10. PubMed ID: 2119926
[TBL] [Abstract][Full Text] [Related]
2. [Apolipoprotein A I-C III-A IV deficiency].
Kato H
Nihon Rinsho; 1994 Dec; 52(12):3253-6. PubMed ID: 7853719
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia.
Ordovas JM; Schaefer EJ; Salem D; Ward RH; Glueck CJ; Vergani C; Wilson PW; Karathanasis SK
N Engl J Med; 1986 Mar; 314(11):671-7. PubMed ID: 3081805
[TBL] [Abstract][Full Text] [Related]
4. Familial apolipoprotein A-I and C-III deficiency, variant II.
Schaefer EJ; Ordovas JM; Law SW; Ghiselli G; Kashyap ML; Srivastava LS; Heaton WH; Albers JJ; Connor WE; Lindgren FT
J Lipid Res; 1985 Sep; 26(9):1089-101. PubMed ID: 3934306
[TBL] [Abstract][Full Text] [Related]
5. [Familial hypoalphalipoproteinemia. Vergani's disease].
Dioguardi N
Minerva Med; 1983 Nov; 74(44):2659-64. PubMed ID: 6657116
[TBL] [Abstract][Full Text] [Related]
6. Apolipoproteins of human plasma high density lipoproteins. Biology, biochemistry and clinical significance.
Scanu AM; Edelstein C; Gordon JI
Clin Physiol Biochem; 1984; 2(2-3):111-22. PubMed ID: 6435927
[TBL] [Abstract][Full Text] [Related]
7. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
Lackner KJ; Dieplinger H; Nowicka G; Schmitz G
J Clin Invest; 1993 Nov; 92(5):2262-73. PubMed ID: 7693760
[TBL] [Abstract][Full Text] [Related]
8. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.
Tian L; Wu J; Fu M; Xu Y; Jia L
Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590
[TBL] [Abstract][Full Text] [Related]
9. Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency.
Schaefer EJ
Arteriosclerosis; 1984; 4(4):303-22. PubMed ID: 6431953
[TBL] [Abstract][Full Text] [Related]
10. Apo E-containing lipoproteins in low or high density lipoprotein deficiency.
Gibson JC; Rubinstein A; Brown WV; Ginsberg HN; Greten H; Norum R; Kayden H
Arteriosclerosis; 1985; 5(4):371-80. PubMed ID: 3925935
[TBL] [Abstract][Full Text] [Related]
11. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
[TBL] [Abstract][Full Text] [Related]
12. Genetic factors influencing apolipoprotein AI and AII levels in a kindred with premature coronary heart disease.
Borecki IB; Laskarzewski P; Rao DC
Genet Epidemiol; 1988; 5(6):393-406. PubMed ID: 3145239
[TBL] [Abstract][Full Text] [Related]
13. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Zambon A; Brown BG; Deeb SS; Brunzell JD
J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
[TBL] [Abstract][Full Text] [Related]
14. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
15. [Hypoalphalipoproteinemia and atherosclerosis. Genetic and biochemical profile of 10 families].
Ahumada Ayala M; Jiménez Villanueva C; Cardoso Saldaña G; Sienra Pérez JC; Zamora González J; Posadas Romero C
Arch Inst Cardiol Mex; 1989; 59(1):9-18. PubMed ID: 2486742
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
[TBL] [Abstract][Full Text] [Related]
17. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation.
Navarro MA; Carpintero R; Acín S; Arbonés-Mainar JM; Calleja L; Carnicer R; Surra JC; Guzmán-García MA; González-Ramón N; Iturralde M; Lampreave F; Piñeiro A; Osada J
Cytokine; 2005 Jul; 31(1):52-63. PubMed ID: 15878672
[TBL] [Abstract][Full Text] [Related]
18. Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization.
Marcil M; Boucher B; Krimbou L; Solymoss BC; Davignon J; Frohlich J; Genest J
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1015-24. PubMed ID: 7627690
[TBL] [Abstract][Full Text] [Related]
19. Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11.
Ordovas JM; Cassidy DK; Civeira F; Bisgaier CL; Schaefer EJ
J Biol Chem; 1989 Oct; 264(28):16339-42. PubMed ID: 2506176
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of apolipoproteins A-I and C-III and severe coronary heart disease.
Hiasa Y; Maeda T; Mori H
Clin Cardiol; 1986 Jul; 9(7):349-52. PubMed ID: 3089658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
